Antifungal combinations against simulated Candida albicans endocardial vegetations

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 6, 2009, Pages 2629-2631

  Pai, Manjunath P ^a,b  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b ORDWAY RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; FLUCYTOSINE; MICAFUNGIN;

ANTIFUNGAL ACTIVITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; CONTROLLED STUDY; ENDOCARDIUM; FUNGAL STRAIN; FUNGUS ISOLATION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; SIMULATION;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; DRUG COMBINATIONS; ECHINOCANDINS; ENDOCARDITIS; FLUCYTOSINE; HUMANS; LIPOPEPTIDES;

EID: 67249165341     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01026-08     Document Type: Article

References (15)

1. Bachmann, S. P., K. VandeWalle, G. Ramage, T. F. Patterson, B. L. Wickes, J. R. Graybill, and J. L. López-Ribot. 2002. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob. Agents Chemother. 46:3591-3596.
2. Baddley, J. W., D. K. Benjamin, Jr., M. Patel, J. Miro, E. Athan, B. Barsic, E. Bouza, L. Clara, T. Elliott, Z. Kanafani, J. Klein, S. Lerakis, D. Levine, D. Spelman, E. Rubinstein, P. Tornos, A. J. Morris, P. Pappas, V. G. Fowler, Jr., V. H. Chu, and C. Cabell. 2008. Candida infective endocarditis. Eur. J. Clin. Microbiol. Infect. Dis. 27:519-529.
3. Bonow, R. O., B. A. Carabello, C. Kanu, A. C. de Leon, Jr., D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, R. A. O'Rourke, C. M. Otto, P. M. Shah, J. S. Shanewise, S. C. Smith, Jr., A. K. Jacobs, C. D. Adams, J. L. Anderson, E. M. Antman, D. P. Faxon, V. Fuster, J. L. Halperin, L. F. Hiratzka, S. A. Hunt, B. W. Lytle, R. Nishimura, R. L. Page, and B. Riegel. 2006. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114:e84-231.
4. Cateau, E., M. H. Rodier, and C. Imbert. 2008. In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth. J. Antimicrob. Chemother. 62:153-155.
5. d'Enfert, C. 2006. Biofilms and their role in the resistance of pathogenic Candida to antifungal agents. Curr. Drug Targets 7:465-470.
6. Ellis, M. E., H. Al-Abdely, A. Sandridge, W. Greer, and W. Ventura. 2001. Fungal endocarditis: evidence in the world literature, 1965-1995. Clin. Infect. Dis. 32:50-62.
7. Jacobson, M. J., K. E. Piper, G. Nguyen, J. M. Steckelberg, and R. Patel. 2008. In vitro activity of anidulafungin against Candida albicans biofilms. Antimicrob. Agents Chemother. 52:2242-2243.
8. Kuhn, D. M., T. George, J. Chandra, P. K. Mukherjee, and M. A. Ghannoum. 2002. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob. Agents Chemother. 46:1773-1780.
9. Mukherjee, P. K., and J. Chandra. 2004. Candida biofilm resistance. Drug Resist. Updat. 7:301-309.
10. Norice, C. T., F. J. Smith, Jr., N. Solis, S. G. Filler, and A. P. Mitchell. 2007. Requirement for Candida albicans Sun41 in biofilm formation and virulence. Eukaryot. Cell 6:2046-2055.
11. Pai, M. P., M. L. Samples, R. C. Mercier, and M. N. Spilde. 2008. Activity and ultrastructural effects of antifungal combinations against simulated Candida endocardial vegetations. Antimicrob. Agents Chemother. 52:2367-2376.
12. Pfaller, M. A., L. Boyken, R. J. Hollis, J. Kroeger, S. A. Messer, S. Tendolkar, and D. J. Diekema. 2008. In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance. J. Clin. Microbiol. 46:150-156.
13. Ramage, G., K. VandeWalle, S. P. Bachmann, B. L. Wickes, and J. L. López-Ribot. 2002. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob. Agents Chemother. 46:3634-3636.
14. Serena, C., M. Mariné, G. Quindós, A. J. Carrillo, J. F. Cano, F. J. Pastor, and J. Guarro. 2008. In vitro interactions of micafungin with amphotericin B against clinical isolates of Candida spp. Antimicrob. Agents Chemother. 52:1529-1532.
15. Shuford, J. A., K. E. Piper, J. M. Steckelberg, and R. Patel. 2007. In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates. Diagn. Microbiol. Infect. Dis. 57:277-281. (Pubitemid 46330658)